Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study

被引：0

作者：

Hidetoshi Kawaguchi

Norikazu Masuda

Takahiro Nakayama

Kenjiro Aogi

Keisei Anan

Yoshinori Ito

Shoichiro Ohtani

Nobuaki Sato

Shigehira Saji

Toshimi Takano

Eriko Tokunaga

Seigo Nakamura

Yoshie Hasegawa

Masaya Hattori

Tomomi Fujisawa

Satoshi Morita

Miki Yamaguchi

Hiroko Yamashita

Toshinari Yamashita

Yutaka Yamamoto

Daisuke Yotsumoto

Masakazu Toi

Shinji Ohno

机构：

[1] Matsuyama Red Cross Hospital,Department of Breast Surgery

[2] NHO Osaka National Hospital,Department of Surgery, Breast Oncology

[3] Osaka International Cancer Institute,Department of Breast and Endocrine Surgery

[4] NHO Shikoku Cancer Center,Department of Breast Oncology

[5] Kitakyushu Municipal Medical Center,Department of Surgery

[6] The Cancer Institute Hospital of JFCR,Department of Breast Medical Oncology

[7] Hiroshima City Hiroshima Citizens Hospital,Department of Breast Surgery

[8] Niigata Cancer Center Hospital,Department of Breast Oncology

[9] Fukushima Medical University,Department of Medical Oncology

[10] Toranomon Hospital,Department of Medical Oncology

[11] Kyushu Cancer Center,Department of Breast Oncology

[12] Showa University School of Medicine,Department of Surgery, Division of Breast Surgical Oncology

[13] Hirosaki Municipal Hospital,Department of Breast Surgery

[14] Aichi Cancer Center Hospital,Department of Breast Oncology

[15] Department of Breast Oncology,Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine

[16] Gunma Prefectural Cancer Center,Department of Breast Surgery

[17] Kyoto University,Department of Breast Surgery

[18] JCHO Kurume General Hospital,Department of Breast and Endocrine Surgery

[19] Hokkaido University Hospital,Department of Breast and Endocrine Surgery

[20] Kanagawa Cancer Center,Department of Breast Surgical Oncology

[21] Kumamoto University Graduate School of Medical Sciences,Department of Breast Surgery, Graduate School of Medicine

[22] Hakuaikai Medical Corporation Sagara Hospital,Breast Oncology Center

[23] Kyoto University,undefined

[24] The Cancer Institute Hospital of JFCR,undefined

来源：

Breast Cancer | 2020年 / 27卷

关键词：

Breast cancer; Antineoplastic agents; Post-menopause; Hormones; Overall survival;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：389 / 398

页数：9

共 10 条

[1] Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study
Kawaguchi, Hidetoshi
Masuda, Norikazu
Nakayama, Takahiro
Aogi, Kenjiro
Anan, Keisei
Ito, Yoshinori
Ohtani, Shoichiro
Sato, Nobuaki
Saji, Shigehira
Takano, Toshimi
Tokunaga, Eriko
Nakamura, Seigo
Hasegawa, Yoshie
Hattori, Masaya
Fujisawa, Tomomi
Morita, Satoshi
Yamaguchi, Miki
Yamashita, Hiroko
Yamashita, Toshinari
Yamamoto, Yutaka
Yotsumoto, Daisuke
Toi, Masakazu
Ohno, Shinji
BREAST CANCER, 2020, 27 (03) : 389 - 398
[2] Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative postmenopausal breast cancer: an ad hoc analysis of the JBCRG-C06 Safari study
Kawaguchi, Hidetoshi
Yamamoto, Yutaka
Saji, Shigehira
Masuda, Norikazu
Nakayama, Takahiro
Aogi, Kenjiro
Anan, Keisei
Ito, Yoshinori
Ohtani, Shoichiro
Sato, Nobuaki
Takano, Toshimi
Tokunaga, Eriko
Nakamura, Seigo
Hasegawa, Yoshie
Hattori, Masaya
Fujisawa, Tomomi
Morita, Satoshi
Yamaguchi, Miki
Yamashita, Hiroko
Yamashita, Toshinari
Yotsumoto, Daisuke
Toi, Masakazu
Ohno, Shinji
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (06) : 545 - 553
[3] Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study
Kawaguchi, Hidetoshi
Masuda, Norikazu
Nakayama, Takahiro
Aogi, Kenjiro
Anan, Keisei
Ito, Yoshinori
Ohtani, Shoichiro
Sato, Nobuaki
Saji, Shigehira
Takano, Toshimi
Tokunaga, Eriko
Nakamura, Seigo
Hasegawa, Yoshie
Hattori, Masaya
Fujisawa, Tomomi
Morita, Satoshi
Yamaguchi, Miki
Yamashita, Hiroko
Yamashita, Toshinari
Yamamoto, Yutaka
Yotsumoto, Daisuke
Toi, Masakazu
Ohno, Shinji
CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (01) : 49 - 54
[4] Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study
Kawaguchi, Hidetoshi
Yamamoto, Yutaka
Saji, Shigehira
Masuda, Norikazu
Nakayama, Takahiro
Aogi, Kenjiro
Anan, Keisei
Ohtani, Shoichiro
Sato, Nobuaki
Takano, Toshimi
Tokunaga, Eriko
Nakamura, Seigo
Hasegawa, Yoshie
Hattori, Masaya
Fujisawa, Tomomi
Morita, Satoshi
Yamaguchi, Miki
Yamashita, Toshinari
Yotsumoto, Daisuke
Toi, Masakazu
Ohno, Shinji
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (03) : 203 - 211
[5] A Real-World Data Retrospective Cohort Study of Low Estrogen Receptor-Positive Early Breast Cancer: Natural History and Treatment Outcomes
Bari, Shahla
Boulware, David
Li, Jiannong
Loftus, Loretta
Muller, Aixa Soyano
Jameel, Zena
Khong, Hung
Czerniecki, Brian J.
Costa, Ricardo L. B.
BREAST CANCER-TARGETS AND THERAPY, 2022, 14 : 199 - 210
[6] Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world multicentre UK study
El Badri, Salma
Tahir, Bilal
Balachandran, Kirsty
Bezecny, Pavel
Britton, Fiona
Davies, Mark
Desouza, Karen
Dixon, Simon
Hills, Daniel
Moe, Maung
Pigott, Thomas
Proctor, Andrew
Shah, Yatri
Simcock, Richard
Stansfeld, Anna
Synowiec, Alicja
Theodoulou, Marianna
Verrill, Mark
Wadhawan, Anshu
Harper-Wynne, Catherine
Wilson, Caroline
BREAST, 2021, 60 : 199 - 205
[7] Association of triple positivity with prognostic parameters and overall survival in a population-based study of 6,122 HER2-positive breast cancer patients: analysis of real-world clinical practice based on a research database
Kolarova, I
Vanasek, J.
Dolezel, M.
Stuk, J.
Hlavka, A.
Dusek, L.
Melichar, B.
Buchler, T.
Ryska, A.
Prausova, J.
Petrakova, K.
Tesarova, P.
Petera, J.
Vosmik, M.
Horackova, K.
Jarkovsky, J.
NEOPLASMA, 2020, 67 (06) : 1373 - 1383
[8] Prognostic factors and benefit populations of ovarian function suppression in premenopausal HR+/HER2+early-stage breast cancer patients who received trastuzumab: Evidence from a real-world study with long-term follow-up
Ju, Jie
Gao, Song-Lin
Wang, Jia-Yu
Sang, Die
Kang, Yi-Kun
Wang, Xue
Yue, Jian
Shuai, You
Qi, Yi-Xin
Yuan, Peng
THORACIC CANCER, 2024, 15 (06) : 439 - 447
[9] Predicting invasive disease-free survival in ER-positive, HER2-negative early breast cancer using the PAM50 risk-of-recurrence score: a retrospective analysis using single-center long-term follow-up data of postmenopausal Japanese patients
Higami, Akane
Takada, Masahiro
Kawaguchi-Sakita, Nobuko
Kawashima, Masahiro
Kawaguchi, Kosuke
Yamaguchi, Ayane
Takeuchi, Yasuhide
Yamada, Yosuke
Toi, Masakazu
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (11) : 1715 - 1720
[10] An XGBoost Machine Learning Based Model for Predicting Ki-67 Value ≥ 15% in T2NXM0 Stage Primary Breast Cancer Receiving Neoadjuvant Chemotherapy Using Clinical Data and Delta-Radiomic Features on Ultrasound Images and Overall Survival Analysis: A 5-Year Postoperative Follow-Up Study
Lu, Yang
Yang, Fei
Tao, Yichao
An, Pang
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23

← 1 →